Healthcare Global Enterprises: Q1 FY2027 Monitoring Agency Report on Rights Issue Proceeds Utilization

Regulatory 6 Aug 2026 · In force· ✓ Verified

Healthcare Global Enterprises Limited, a listed healthcare services provider headquartered in Bengaluru, submitted its quarterly monitoring agency report to the NSE in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulation 32(6)) and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (Regulation 82(4)). The report, issued by independent monitoring agency CARE Ratings Limited, covers the three-month period ended 30 June 2026 and certifies the utilization of proceeds from a rights issue. Such reports are mandatory for listed issuers following a rights offering to ensure capital raised is deployed in accordance with the stated…

Why it mattersRights issue monitoring is a mandatory quarterly disclosure gate under SEBI ICDR and LODR regimes; delays or fund diversion trigger exchange suspension and regulator action-this filing confirms HCG met its disclosure obligation on schedule.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals